Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Mylan II B.V.
| Metric | Mylan II B.V. Healthcare |
|---|---|
| Quality Score | 67 / 100 |
| Revenue (latest) | $11.37B |
| Net income (latest) | $17M |
| Operating margin | 6.3% |
| Net margin | 0.1% |
| Return on equity | 0.1% |
| Return on assets | 0.1% |
| Return on capital (ROCE) | 2.8% |
| Debt / equity | 1.63× |
| Revenue growth (YoY) | 0.9% |
| Altman Z″ (distress) | 1.68 |
| Accruals / assets | −5.7% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.